{"id":"intravenous-tirofiban","safety":{"commonSideEffects":[{"rate":"1.4-4.0","effect":"Bleeding"},{"rate":"0.5-1.5","effect":"Thrombocytopenia"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Bradycardia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tirofiban reversibly inhibits the glycoprotein IIb/IIIa receptor on platelet surfaces, which is the final common pathway for platelet aggregation. By blocking this receptor, tirofiban prevents platelets from clumping together and forming thrombi, reducing the risk of acute ischemic events in patients with acute coronary syndromes or undergoing percutaneous coronary intervention.","oneSentence":"Tirofiban is a glycoprotein IIb/IIIa inhibitor that blocks platelet aggregation by preventing fibrinogen binding to platelet receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:48:45.997Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome (unstable angina and non-ST elevation myocardial infarction)"},{"name":"Percutaneous coronary intervention"}]},"trialDetails":[{"nctId":"NCT06265051","phase":"PHASE2, PHASE3","title":"Tirofiban After Successful MT Recanalization in AIS","status":"COMPLETED","sponsor":"Xiang Luo","startDate":"2024-04-09","conditions":"Acute Ischemic Stroke, Vessel Occlusion","enrollment":1380},{"nctId":"NCT06037889","phase":"PHASE3","title":"Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2023-11-09","conditions":"Branch Atheromatous Disease","enrollment":516},{"nctId":"NCT05225961","phase":"PHASE4","title":"ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-05-01","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT07379190","phase":"PHASE3","title":"HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)","status":"NOT_YET_RECRUITING","sponsor":"Weifang Medical University","startDate":"2026-02-01","conditions":"Stroke, Acute, Stroke, Ischemic, Cerebral Infarction","enrollment":458},{"nctId":"NCT07335107","phase":"PHASE3","title":"Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-01-12","conditions":"Acute Ischemic Stroke","enrollment":564},{"nctId":"NCT06210633","phase":"","title":"Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke","status":"RECRUITING","sponsor":"Zhongming Qiu","startDate":"2024-01-20","conditions":"Acute Ischemic Stroke (AIS), Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":1000},{"nctId":"NCT06045156","phase":"NA","title":"Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2024-04-29","conditions":"Acute Ischemic Stroke","enrollment":1084},{"nctId":"NCT05728333","phase":"PHASE2, PHASE3","title":"Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke","status":"RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2023-11-28","conditions":"Stroke, Acute Ischemic","enrollment":800},{"nctId":"NCT05604638","phase":"PHASE3","title":"Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Guangxi Medical University","startDate":"2024-04-24","conditions":"Acute Ischemic Stroke","enrollment":348},{"nctId":"NCT07290751","phase":"PHASE4","title":"Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-11-11","conditions":"Acute Ischemic Stroke","enrollment":976},{"nctId":"NCT07135089","phase":"PHASE3","title":"Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-11-13","conditions":"Stroke, Ischemic","enrollment":870},{"nctId":"NCT07111806","phase":"PHASE3","title":"Intravenous Tirofiban After Delayed Thrombolysis in Stroke","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-12-01","conditions":"Acute Ischemic Stroke","enrollment":852},{"nctId":"NCT06134622","phase":"PHASE3","title":"Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)","status":"COMPLETED","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2024-03-14","conditions":"Acute Ischemic Stroke","enrollment":832},{"nctId":"NCT06826144","phase":"NA","title":"Chronic Remote Ischemic Conditioning in Small Infarctions Associated with Stent-assisted Coiling of Unruptured Intracranial Aneurysms","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-02-20","conditions":"Unruptured Intracranial Aneurysm, Infarction Cerebral","enrollment":84},{"nctId":"NCT01717573","phase":"NA","title":"Deferred Stent Trial in STEMI","status":"COMPLETED","sponsor":"NHS National Waiting Times Centre Board","startDate":"2012-03","conditions":"ST-Elevation Myocardial Infarction","enrollment":101},{"nctId":"NCT06587347","phase":"PHASE2, PHASE3","title":"Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-20","conditions":"Acute Stroke, Ischemic Stroke, Acute, Cerebral Infarction","enrollment":302},{"nctId":"NCT05735301","phase":"NA","title":"Patient Selection Using MR With Non-Perfusion Imaging for Endovascular Treatment Within 6 to 24 Hours","status":"RECRUITING","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-01-01","conditions":"Endovascular Thrombectomy","enrollment":352},{"nctId":"NCT06373042","phase":"PHASE2, PHASE3","title":"Tirofiban for Successful Endovascular Stroke Thrombectomy","status":"NOT_YET_RECRUITING","sponsor":"Zhongming Qiu","startDate":"2024-07-31","conditions":"Stroke, Acute Ischemic","enrollment":712},{"nctId":"NCT04851457","phase":"PHASE2","title":"One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China","status":"COMPLETED","sponsor":"Shanghai East Hospital","startDate":"2021-04-06","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT05733507","phase":"","title":"Tirofiban Plus Intravenous Thrombolysis in Acute Anterior Choroidal Infarction or Paramedian Pontine Infarction","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2023-04-03","conditions":"Acute Anterior Choroidal Infarction (ACI), Paramedian Pontine Infarction (IPP)","enrollment":48},{"nctId":"NCT05902000","phase":"NA","title":"Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion","status":"UNKNOWN","sponsor":"Xueli Cai","startDate":"2023-06-14","conditions":"Thrombectomy, Tandem Occlusion, Stroke","enrollment":222},{"nctId":"NCT05841147","phase":"PHASE4","title":"Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban","status":"UNKNOWN","sponsor":"Lu Hua","startDate":"2023-04-25","conditions":"Intracranial Aneurysm","enrollment":70},{"nctId":"NCT05188417","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"GrandPharma (China) Co., Ltd.","startDate":"2021-12-09","conditions":"Acute Ischemic Stroke","enrollment":266},{"nctId":"NCT03691727","phase":"PHASE1, PHASE2","title":"Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)","status":"COMPLETED","sponsor":"David Hasan","startDate":"2019-01-24","conditions":"Subarachnoid Hemorrhage, Aneurysmal","enrollment":30},{"nctId":"NCT03357133","phase":"PHASE2, PHASE3","title":"Tirofiban for Patients Treated With Alteplase","status":"TERMINATED","sponsor":"Capital Medical University","startDate":"2017-12-16","conditions":"Ischemic Stroke","enrollment":30},{"nctId":"NCT02978040","phase":"PHASE4","title":"Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2017-07-04","conditions":"Coronary Artery Disease, STEMI - ST Elevation Myocardial Infarction","enrollment":122},{"nctId":"NCT03797729","phase":"PHASE4","title":"Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2019-05-14","conditions":"ST Elevation Myocardial Infarction","enrollment":500},{"nctId":"NCT01103440","phase":"PHASE2","title":"Aspirin Resistance and Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2007-04","conditions":"Stable Angina","enrollment":36},{"nctId":"NCT00713557","phase":"","title":"Shanghai Registry of Acute Coronary Events","status":"TERMINATED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2005-03","conditions":"Coronary Artery Disease, Acute Coronary Syndrome","enrollment":20000},{"nctId":"NCT01087723","phase":"PHASE3","title":"European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2010-03","conditions":"Acute Coronary Syndrome","enrollment":2198},{"nctId":"NCT00445263","phase":"PHASE4","title":"Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation","status":"TERMINATED","sponsor":"Hospital Avicenne","startDate":"2007-03","conditions":"CORONARY DISEASE","enrollment":170},{"nctId":"NCT01696110","phase":"PHASE4","title":"BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial.","status":"COMPLETED","sponsor":"Shenyang Northern Hospital","startDate":"2012-08","conditions":"Acute Myocardial Infarction, Percutaneous Coronary Intervention","enrollment":2194},{"nctId":"NCT01336348","phase":"PHASE3","title":"Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse","status":"COMPLETED","sponsor":"Università degli Studi di Ferrara","startDate":"2010-04","conditions":"ST Segment Elevation Myocardial Infarction","enrollment":100},{"nctId":"NCT01109134","phase":"PHASE3","title":"Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients","status":"COMPLETED","sponsor":"Kosuyolu Heart Hospital","startDate":"2008-09","conditions":"Acute Myocardial Infarction","enrollment":49}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":139,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Intravenous Tirofiban","genericName":"Intravenous Tirofiban","companyName":"Beijing Tiantan Hospital","companyId":"beijing-tiantan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tirofiban is a glycoprotein IIb/IIIa inhibitor that blocks platelet aggregation by preventing fibrinogen binding to platelet receptors. Used for Acute coronary syndrome (unstable angina and non-ST elevation myocardial infarction), Percutaneous coronary intervention.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}